Eric Allyn, Former Chairman Of Welch Allyn, Joins The Board Of Health Care Originals
Tuesday, August 28, 2018
Health Care Originals (HCO), the award-winning digital health startup is pleased to announce that Eric Allyn, former Chairman of Welch Allyn, has joined its Board of Directors.
Eric Allyn is the former Chairman of the Board of Welch Allyn, Inc, which was sold to Hill Rom in 2015. In addition, Eric is founder and managing partner of two private investment funds, serves as chairman of the investment committee of a $90M private foundation, is managing partner of the Allyn Family Office, and serves on the board of directors of many organizations, including GOJO (makers of Purell), Pharm-Tech Industries, Auburn Community Hospital (former Chairman), and Healthcare Trustees of NYS (Chairman).
"HCO welcomes Eric to our board especially at this time when we are poised for growth. As a digital health startup deploying our purpose-built, IoT, Edge-Computing wearable, we're excited to have the former leader of one of the more accomplished Medical Device companies in the world be part of our growth process. Over the last few years of getting to know Eric, we've become convinced that our visions for healthcare are aligned, and feel confident that he will be a great resource when navigating the growth challenges ahead strategically," said Jared Dwarika, Co-Founder of HCO.
"I'm thrilled to join the Board of Directors of HCO. I have known the team for a few years, and have been impressed with their innovation, technology and capital efficiency. They have brought their first product to market, early feedback is very positive, and have successfully engaged a number of commercial contracts. I led Welch Allyn, a 100+ year old, $700M manufacturer of Medical Devices, employing 2,650 world-wide, for many years, and that company was instrumental in bringing telemetry to the physician's office, transitioning certain levels of care from hospitals to the physician's office. I see HCO's platform technology as central to the paradigm shift that is occurring and must occur in healthcare - one in which individuality of disease and medication-response are recognized, and where consumers have the power to understand and sustainably change behavior for better health through objective data and insights. I'm looking forward to helping HCO as they grow," said Eric.
Keith Wilson, Managing Partner of Cranberry Capital, and Director of HCO echoed these sentiments. "The team has done a great job of commercializing their platform technology, bringing different use cases to market, and raising awareness of the significant positive impact they can make for those with chronic respiratory disease and their caregivers. I'm looking forward to adding Eric's insight and guidance to our growth strategy."